Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to UY29310ApriorityCriticalpatent/UY29310A1/en
Publication of UY29310A1publicationCriticalpatent/UY29310A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a compuestos de 1,2-diarilimidazol de fórmula I, y procedimientos para la preparación de dichos compuestos, su utilización en el tratamiento de la obesidad y trastornos neurológicos y psiquiátricos, a métodos para su utilización terapéutica y a composiciones farmacéuticas que los contienen.The present invention relates to 1,2-diarylimidazole compounds of formula I, and methods for the preparation of said compounds, their use in the treatment of obesity and neurological and psychiatric disorders, to methods for therapeutic use and to pharmaceutical compositions which They contain them.
SUBSTITUTED DERIVATIVES OF 4,5,6,7-TETRAHIDROPIRROLO (3,2, C) PIRIDIN-4-ONA AND 4,5-TETRAHIDROPIRROLO (3,2, C) PIRIDIN-4-ONA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESSES OF PREPARATION AND APPLICATIONS